1-[3-(2-Hydroxy-ethoxyMethyl)-pyrrolidin-1-yl]-ethanone
|
- $1378
- Product name: 1-[3-(2-Hydroxy-ethoxyMethyl)-pyrrolidin-1-yl]-ethanone
- CAS: 1353980-70-7
- MF: C9H17NO3
- MW: 187.24
- EINECS:
- MDL Number:MFCD21092267
- Synonyms:1-[3-(2-Hydroxy-ethoxyMethyl)-pyrrolidin-1-yl]-ethanone;Ethanone, 1-[3-[(2-hydroxyethoxy)methyl]-1-pyrrolidinyl]-
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM497621
- Product description1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1378
- Updated2026-05-20
- Buy
- ManufacturerChemenu
- Product numberCM497621
- Product description1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11284824
- Product description1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11284824
- Product description1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM497621 | 1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97% | 1g | $1378 | 2026-05-20 | Buy |
| Chemenu | CM497621 | 1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97% | 1g | $1378 | 2026-05-26 | Buy |
| Crysdot | CD11284824 | 1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97% | 1g | $1378 | 2026-05-26 | Buy |
| Crysdot | CD11284824 | 1-(3-((2-Hydroxyethoxy)methyl)pyrrolidin-1-yl)ethanone 97% | 1g | $1378 | 2021-12-16 | Buy |
Properties
Boiling point :352.2±12.0 °C(Predicted)
Density :1.108±0.06 g/cm3(Predicted)
pka :14.40±0.10(Predicted)
Density :1.108±0.06 g/cm3(Predicted)
pka :14.40±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




